Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt

Identifieur interne : 001B23 ( Main/Exploration ); précédent : 001B22; suivant : 001B24

Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt

Auteurs : Philip J. Thompson [Australie] ; Neil L. Misso [Australie] ; John Woods [Australie]

Source :

RBID : ISTEX:F30D2E183BDBBC35E40562F8BDF850AB2ECC0932

Abstract

Abstract:  Very severe asthma and local pulmonary steroid resistance causes major problems for patients, physicians and the health system at large. It usually results in multiple admissions to hospital and high morbidity. Omalizumab was used to treat such patients with success. However, in doing so, it raised a number of issues relating to the best methods of using this treatment in such patients.

Url:
DOI: 10.1111/j.1440-1843.2007.01017.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt</title>
<author>
<name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
</author>
<author>
<name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
</author>
<author>
<name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F30D2E183BDBBC35E40562F8BDF850AB2ECC0932</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1111/j.1440-1843.2007.01017.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7QGVFDV9-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002365</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002365</idno>
<idno type="wicri:Area/Istex/Curation">002365</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A06</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A06</idno>
<idno type="wicri:doubleKey">1323-7799:2007:Thompson P:omalizumab:xolair:in</idno>
<idno type="wicri:Area/Main/Merge">001B34</idno>
<idno type="wicri:Area/Main/Curation">001B23</idno>
<idno type="wicri:Area/Main/Exploration">001B23</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt</title>
<author>
<name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Respirology</title>
<title level="j" type="sub">The Clinical Management of Severe Asthma, Canberra, Australia</title>
<title level="j" type="alt">RESPIROLOGY</title>
<idno type="ISSN">1323-7799</idno>
<idno type="eISSN">1440-1843</idno>
<imprint>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">s3</biblScope>
<biblScope unit="page" from="S29">S29</biblScope>
<biblScope unit="page" to="S34">S34</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2007-11">2007-11</date>
</imprint>
<idno type="ISSN">1323-7799</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1323-7799</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract:  Very severe asthma and local pulmonary steroid resistance causes major problems for patients, physicians and the health system at large. It usually results in multiple admissions to hospital and high morbidity. Omalizumab was used to treat such patients with success. However, in doing so, it raised a number of issues relating to the best methods of using this treatment in such patients.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
</noRegion>
<name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
<name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B23 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B23 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F30D2E183BDBBC35E40562F8BDF850AB2ECC0932
   |texte=   Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021